Sbir phase i topic 392: targeted radionuclide therapy of metastatic liver cancer: patient specific optimization
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91019C00047
- Awardee
-
Radiopharmaceutical Imaging And Dosimetry, LLC UEI CM3LK9281JS7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,275
Award facts
- Opportunity
-
- PHS20191 Solicitation number
- Contract value 100% obligated
- $299,275.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21231, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $299,275 |
About this award
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Radiopharmaceutical Imaging and Dosimetry, LLC, doing business as Radiopharmaceutical Imaging & Dosimetry LLC, a small business. The contract, valued at $299,275, is for a Small Business Innovation Research (SBIR) Phase I project to optimize targeted radionuclide therapy for metastatic liver cancer patients. This contract supports the NCI's broader efforts to develop innovative cancer treatment strategies.
Quick answers
Who was awarded contract 75N91019C00047?
75N91019C00047 was awarded to Radiopharmaceutical Imaging And Dosimetry, LLC by National Cancer Institute (National Institutes of Health) on September 16, 2019.
How much is contract 75N91019C00047 worth?
The government has obligated $299,275 on 75N91019C00047.
Was contract 75N91019C00047 competed?
The extent of competition for 75N91019C00047 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award